LB I Group Overview

  • Investor Type
  • PE/​Buyout
  • Status
  • Inactive
  • Investments
  • 9
  • Portfolio
  • 1
  • Exits
  • 4
Exits

LB I Group General Information

Description

LB I Group was a New York, New York based private equity firm which was a direct wholly-owned subsidiary of Lehman Brothers.

Contact Information

Investor Status
Out of Business
Primary Investor Type
PE/Buyout
Primary Office
  • 399 Park Avenue
  • New York, NY 10023
  • United States

LB I Group Investments (9)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000 0000000000000 24-Mar-2008 0000 00000 Pharmaceuticals Profitable
00000000 00000000 16-Feb-2007 0000 000.00 Biotechnology Generating Revenue/Not Profitable
0000000 07-Nov-2006 0000 0000 Pharmaceuticals Generating Revenue
00000000 00000000 08-May-2006 0000 0000 Biotechnology Generating Revenue/Not Profitable
CASI Pharmaceuticals 27-Dec-2004 PIPE 0000 Biotechnology Generating Revenue/Not Profitable
You’re viewing 5 of 9 investments. Get the full list »
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LB I Group Exits (4)

Company Name Exit Date Exit Type Exit Size
00000 000000000000 28-Feb-2018 000000000000000000 00.00
0000 0000000000000 23-Jan-2012 000000000 00000000 0000
0000 0000000000000 21-Jun-2010 000000000000000000 00.00
Cytogen 08-May-2008 Buyout/LBO 0000
To view LB I Group’s complete exits history, request access »

LB I Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial